BridgeBio Pharma, Inc. (BBIO)
收市後：
| 前收市價 | 27.27 |
| 開市 | 27.65 |
| 買盤 | 26.14 x 800 |
| 賣出價 | 28.40 x 1100 |
| 今日波幅 | 26.22 - 27.75 |
| 52 週波幅 | 6.64 - 36.36 |
| 成交量 | |
| 平均成交量 | 3,081,295 |
| 市值 | 4.4B |
| Beta 值 (5 年，每月) | 0.96 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -3.60 |
| 業績公佈日 | 2023年11月01日 - 2023年11月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 46.60 |
InvestorPlaceBuy List Alert: 3 Pharma Stocks with Positive Trial Updates
The pharmaceutical industry is one of the most dynamic and innovative sectors in the world. It is constantly developing new drugs and treatments to address various health challenges and improve the quality of life of millions of people. However, not every pharma company is successful in producing positive clinical trial results. If you just took a quick glance at the performance charts of a couple of biotech focused exchange traded funds (ETFs), such as ARK Genomic Revolution ETF (NYSEARCA:ARKG)
Insider Monkey15 Best Performing Stocks in the Last 6 Months
In this article, we discuss 15 best performing stocks in the last 6 months. If you want to skip our detailed discussion on the stock market, head directly to 5 Best Performing Stocks in the Last 6 Months. As per BlackRock’s findings, equity performance has surpassed predictions in the first half of 2023. In spite […]
Insider Monkey12 Best Biotech ETFs To Buy
In this article, we discuss 12 best biotech ETFs to buy. If you want to skip our detailed discussion on the biotech industry, head directly to 5 Best Biotech ETFs To Buy. According to Precedence Research, the worldwide biotechnology market was valued at approximately $1,224.31 billion in 2022. It is projected to reach a value […]
